Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anti-Microbialvior BioteQ CoROCO:6864 +1.20%61 PS Ratio is 2,000.00 as of Jul. 24, 2026, which is 26% below its 10-year median of 2,719.05. GuruFocus rates ROCO:6864 with a GF Score™ of 61/100 and a GF Value™ of NT$25.38 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 929 Biotechnology companies, Anti-Microbialvior BioteQ Co ranks worse than 97.31% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Anti-Microbialvior BioteQ Co's share price is NT$42.00.
Anti-Microbialvior BioteQ Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.02. Hence, Anti-Microbialvior BioteQ Co's PS Ratio for today is 2,000.00.
Good Sign:
Anti-Microbial Savior BioteQ Co Ltd stock PS Ratio (=2040.48) is close to 1-year low of 2040.48.
The historical rank and industry rank for Anti-Microbialvior BioteQ Co's PS Ratio or its related term are showing as below:
ROCO:6864'
s PS Ratio Range Over the Past 10 Years
Min: 216.81 Med: 2719.05 Max: 10532.51
Current: 2000
During the past 8 years, Anti-Microbialvior BioteQ Co's highest PS Ratio was 10532.51. The lowest was 216.81. And the median was 2719.05.
ROCO:6864's PS Ratio is ranked worse than 97.31% of 929
companies
in the Biotechnology industry
Industry Median: 9.13
vs ROCO:6864: 2000.00
During the past 8 years, Anti-Microbialvior BioteQ Co's highest 3-Year average Revenue per Share Growth Rate was 56.00% per year. The lowest was -41.50% per year. And the median was 50.00% per year.
Back to Basics: PS Ratio
Anti-Microbialvior BioteQ Co (ROCO:6864) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Anti-Microbialvior BioteQ Co PS Ratio Related Terms
Anti-Microbialvior BioteQ Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6864 vs VRTX, REGN, ALNY: PS Ratio Comparison
For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anti-Microbialvior BioteQ Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Anti-Microbialvior BioteQ Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Anti-Microbialvior BioteQ Co's Share Price of today is NT$42.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anti-Microbialvior BioteQ Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Anti-Microbialvior BioteQ Co (ROCO:6864) has a PS Ratio of 2,000.00 as of Jul. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Anti-Microbialvior BioteQ Co and its competitors. This is 26% below median its historical median of 2,719.05. Over the past decade, Anti-Microbialvior BioteQ Co's PS Ratio has ranged from 216.81 to 10,532.51. According to the industry distribution chart, Anti-Microbialvior BioteQ Co ranks #904 out of 929 companies in the Biotechnology industry, placing it in the top 97.3%.
Is Anti-Microbialvior BioteQ Co's PS Ratio too high?
Anti-Microbialvior BioteQ Co's current PS Ratio of 2,000.00 is 26% below median its 10-year median of 2,719.05. Over the past 10 years, this metric has ranged from a low of 216.81 to a high of 10,532.51. The Biotechnology industry median PS Ratio is 9.13. Anti-Microbialvior BioteQ Co's value of 2,000.00 is 21805.8% above this industry median. Based on the distribution chart, Anti-Microbialvior BioteQ Co ranks #904 out of 929 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Anti-Microbialvior BioteQ Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Anti-Microbialvior BioteQ Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anti-Microbialvior BioteQ Co ranks #904 out of 929 companies for PS Ratio. This places Anti-Microbialvior BioteQ Co in the lower half of its industry. The industry median PS Ratio is 9.13. Anti-Microbialvior BioteQ Co's value of 2,000.00 is 21805.8% above this benchmark. Historically, Anti-Microbialvior BioteQ Co's own PS Ratio has ranged from 216.81 to 10,532.51 over the past decade. While the company's 10-year median is 2,719.05 vs. the industry median of 9.13, Anti-Microbialvior BioteQ Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.13, based on 929 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anti-Microbialvior BioteQ Co's current PS Ratio of 2,000.00 is 21805.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Anti-Microbialvior BioteQ Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anti-Microbialvior BioteQ Co's current PS Ratio is 2,000.00, which is 26% below median its own 10-year median of 2,719.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anti-Microbialvior BioteQ Co stock overvalued right now?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co (ROCO:6864) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$25.38, compared to a current price of NT$42.00 — trading 65.5% above its estimated fair value. The current PS Ratio is 2,000.00, which is 26% below median its 10-year median of 2,719.05 and 21805.8% above the Biotechnology industry median of 9.13. Anti-Microbialvior BioteQ Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Anti-Microbialvior BioteQ Co (ROCO:6864), the current PS Ratio is 2,000.00 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anti-Microbialvior BioteQ Co (ROCO:6864) Overvalued in 2026?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co stock appears to be overvalued.
The current stock price of NT$42.00 is trading 65.5% above its estimated GF Value™ of NT$25.38.
GuruFocus considers Anti-Microbialvior BioteQ Co to be Significantly Overvalued.
Key valuation signals for ROCO:6864:
PS Ratio: 2,000.00 (26% below median its 10-year median of 2,719.05)
GF Value™: NT$25.38 vs. price of NT$42.00 (65.5% above fair value)
Industry Position: 21805.8% above the Biotechnology median (#904 of 929)
No single metric tells the full story. See the ROCO:6864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6864 has been successfully added to your 
